Kevin Finney

Kevin Finney is a declared insider of Vaxart, Inc., with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 28 January 2025 to 16 July 2026.

On the market, this insider has only ever bought: 6 purchases, €53k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants.

Half of the purchases are above €7,750 and half below. 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 20 July 2026 came the latest disclosure, a share grant in Vaxart, Inc. The last purchase on record was published on 19 August 2025, which is 430 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.